Interferon alfa-2b biosimilar (Virchow Group)

干扰素α-2b生物类似药 (Virchow Group)

Report date: 2025/01/07 14:46:53

Base Information

Drug NameInterferon alfa-2b biosimilar (Virchow Group)
Drug Alias NameInterferon alpha-2b biosimilar干扰素α-2b生物类似药干扰素α-2b生物仿制药Interferon Alpha 2b
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionImmunostimulantsInterferon alpha/beta receptor agonistsInnate antiviral immune response inducers
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVirchow Group
China Registration ClassN/A

Develop Information

Active CompaniesVirchow Group
Inactive CompaniesN/A
Active IndicationsHepatitis CHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A